Publications by authors named "Mikhail Martchenko Shilman"

Article Synopsis
  • Anthrax is a serious disease that can almost always be deadly because of a harmful toxin it produces.
  • Researchers studied a drug called amodiaquine (AQ), which can help stop this toxin from harming the body.
  • Tests on mice, rabbits, and humans showed that AQ significantly increased survival rates in infected animals and seemed safe for people when used correctly.
View Article and Find Full Text PDF

The genders of vary in their sensitivities to microbial pathogens. While many of the immunity-related genes are located on the X chromosome, the polymorphisms within the Y chromosome were also shown to affect the immunity of flies. In this study, we investigated the necessity of individual genes on the Y chromosome (Y-genes) for male sensitivity to microbes.

View Article and Find Full Text PDF

Control of fungal pathogens is increasingly problematic due to the limited number of effective drugs available for antifungal therapy. Conventional antifungal drugs could also trigger human cytotoxicity associated with the kidneys and liver, including the generation of reactive oxygen species. Moreover, increased incidences of fungal resistance to the classes of azoles, such as fluconazole, itraconazole, voriconazole, or posaconazole, or echinocandins, including caspofungin, anidulafungin, or micafungin, have been documented.

View Article and Find Full Text PDF

The rising prevalence of multidrug-resistant hospital-acquired infections has increased the need for new antibacterial agents. In this study, a library of 1586 FDA-approved drugs was screened against , a representative of the complex. Three compounds were found to have previously undiscovered antibacterial properties against : antifungal Miconazole, anthelminthic Dichlorophen, and Bithionol.

View Article and Find Full Text PDF

Of the numerous infectious diseases afflicting humans, anthrax disease, caused by , poses a major threat in its virulence and lack of effective treatment. The currently lacking standards of care, as well as the lengthy drug approval process, demonstrate the pressing demand for treatment for infections. The present study screened 1586 clinically approved drugs in an attempt to identify repurposable compounds against , a relative strain that shares many physical and genetic characteristics with .

View Article and Find Full Text PDF

Anthrax is a major zoonotic disease of wildlife, and in places like West Africa, it can be caused by Bacillus anthracis in arid nonsylvatic savannahs, and by B. cereus biovar anthracis (Bcbva) in sylvatic rainforests. Bcbva-caused anthrax has been implicated in as much as 38% of mortality in rainforest ecosystems, where insects can enhance the transmission of anthrax-causing bacteria.

View Article and Find Full Text PDF

Background: Vertebrate glucocorticoid receptor (GR) is an evolutionary-conserved cortisol-regulated nuclear receptor that controls key metabolic and developmental pathways. Upon binding to cortisol, GR acts as an immunosuppressive transcription factor. Drosophila melanogaster, a model organism to study innate immunity, can also be immunosuppressed by glucocorticoids.

View Article and Find Full Text PDF
Article Synopsis
  • The Zika virus (ZIKV) is a significant human pathogen, and previous research has highlighted antibodies from Zika patients that target specific regions on the virus's envelope proteins, known as E dimer epitopes (EDE).
  • The study involved immunizing mice with ZIKV components and analyzing their immune response, particularly the ability of antibodies to bind to specific viral epitopes and neutralize the virus in laboratory tests.
  • Findings indicate that both human Zika patient sera and mouse antibodies can recognize and neutralize ZIKV by binding to different forms of the glycan loop on envelope proteins, leading to a new classification of these antibodies into EME1 and EME2 based on their glycan-binding requirements.
View Article and Find Full Text PDF

Trypanosoma brucei are unicellular parasites endemic to Sub-Saharan Africa that cause fatal disease in humans and animals. Infection with these parasites is caused by the bite of the tsetse fly vector, and parasites living extracellularly in the blood of infected animals evade the host immune system through antigenic variation. Existing drugs for Human and Animal African Trypanosomiasis are difficult to administer and can have serious side effects.

View Article and Find Full Text PDF